MITF and melanoma: Given that i) miR-579-3p is a negative regulator of BRAF-V600-MAPK signaling [13] and ii) miR-579-3p expression is under the transcriptional control of MITF, we decided to measure MITF protein levels following MAPK signaling pathway inhibition in BRAF-mutant melanoma cells.